日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Immunometabolic disorders in type 2 diabetes mellitus mediated by NLRP3 inflammasome activation and methods of pharmacological correction thereof]

[NLRP3炎症小体激活介导的2型糖尿病免疫代谢紊乱及其药理学矫正方法]

Cheplyaeva, N I; Babkov, D A; Lukyanov, A V; Danilov, R D; Spasov, A A

Resveratrol and Extra Virgin Olive Oil: Protective Agents Against Age-Related Disease

白藜芦醇和特级初榨橄榄油:对抗衰老相关疾病的保护剂

Morkovin, Evgeny; Litvinov, Roman; Koushner, Alexey; Babkov, Denis

Derivatization of Abietane Acids by Peptide-like Substituents Leads to Submicromolar Cytotoxicity at NCI-60 Panel

肽类取代基对枞烷酸的衍生化在NCI-60细胞毒性试验中表现出亚微摩尔级的细胞毒性

Tretyakova, Elena; Smirnova, Anna; Babkov, Denis; Kazakova, Oxana

Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain

可溶性环氧化物水解酶抑制剂AMHDU治疗神经性疼痛的临床前评价

Denis Babkov ,Natalya Eliseeva ,Kristina Adzhienko ,Viktoria Bagmetova ,Dmitry Danilov ,Cynthia B McReynolds ,Christophe Morisseau ,Bruce D Hammock ,Vladimir Burmistrov

New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents

具有洛尼达明基团的新型有机金属Ru(II)化合物作为抗肿瘤药物

Shutkov, Ilya A; Okulova, Yulia N; Mazur, Dmitrii M; Melnichuk, Nikolai A; Babkov, Denis A; Sokolova, Elena V; Spasov, Alexander A; Milaeva, Elena R; Nazarov, Alexey A

3-Arylidene-2-oxindoles as GSK3β inhibitors and anti-thrombotic agents

3-亚芳基-2-氧吲哚类化合物作为GSK3β抑制剂和抗血栓药物

Babkov, Denis; Bezsonova, Elena; Sirotenko, Viktor; Othman, Elias; Klochkov, Vladlen; Sosonyuk, Sergey; Lozinskaya, Natalia; Spasov, Alexander

New Molecules of Diterpene Origin with Inhibitory Properties toward α-Glucosidase

具有抑制α-葡萄糖苷酶活性的新型二萜类化合物

Tretyakova, Elena; Smirnova, Irina; Kazakova, Oxana; Nguyen, Ha Thi Thu; Shevchenko, Alina; Sokolova, Elena; Babkov, Denis; Spasov, Alexander

From Marine Metabolites to the Drugs of the Future: Squalamine, Trodusquemine, Their Steroid and Triterpene Analogues

从海洋代谢物到未来药物:鲨胺、特罗杜斯奎明及其甾类和三萜类似物

Kazakova, Oxana; Giniyatullina, Gulnara; Babkov, Denis; Wimmer, Zdenek

CK2 Inhibition and Antitumor Activity of 4,7-Dihydro-6-nitroazolo[1,5-a]pyrimidines

4,7-二氢-6-硝基唑并[1,5-a]嘧啶对 CK2 的抑制作用及抗肿瘤活性

Daniil N Lyapustin, Svetlana K Kotovskaya, Ilya I Butorin, Evgeny N Ulomsky, Vladimir L Rusinov, Denis A Babkov, Alexander A Pokhlebin, Alexander A Spasov, Vsevolod V Melekhin, Maria D Tokhtueva, Anna V Shcheglova, Oleg G Makeev

6-(Tetrazol-5-yl)-7-aminoazolo[1,5- a]pyrimidines as Novel Potent CK2 Inhibitors

6-(四唑-5-基)-7-氨基唑并[1,5- a]嘧啶作为新型强效 CK2 抑制剂

Grigoriy V Urakov, Konstantin V Savateev, Svetlana K Kotovskaya, Vladimir L Rusinov, Alexandr A Spasov, Denis A Babkov, Elena V Sokolova